Compared with CART-CD19/saline-treated mice, an increase in the percentage of M8-specific T cells in the treated tumor was observed in all other groups, but this only reached statistical significance in the CART-gp75/STING-L group (figure 4A). The gene discussed is CD19; the disease is neoplasm.